Neuromodulation Parameter Efficacy
Not Applicable
Recruiting
- Conditions
- Chronic Pain
- Registration Number
- NCT04933370
- Lead Sponsor
- Alberta Health Services, Calgary
- Brief Summary
The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.
- Detailed Description
Different stimulation parameters will be tried in a blinded fashion to compare efficacy.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Patients who are candidates for, and have been consented for, implantation of a neuromodulation device.
Exclusion Criteria
- Non-English speaking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Change in baseline pain measures 6 months Pain outcomes measured using visual analogue scale
- Secondary Outcome Measures
Name Time Method Effect of stimulation on quality of life 6 months As measured using EQ-5D-3L
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie neuromodulation efficacy in chronic pain management?
How do different stimulation paradigms compare to standard-of-care treatments for chronic pain?
Which biomarkers are associated with patient response to neuromodulation therapies in chronic pain?
What are the potential adverse events of neuromodulation and how are they managed in clinical trials?
Are there combination approaches or competitor drugs that enhance neuromodulation outcomes for chronic pain?
Trial Locations
- Locations (1)
University of Calgary
🇨🇦Calgary, Alberta, Canada
University of Calgary🇨🇦Calgary, Alberta, CanadaFady Girgis, MDContact4039446497fmgirgis@ucalgary.ca